Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nauck

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 4, 1994
A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8R Ziesche, M Roth, E Papakonstantinou, et al.
The Journal of Experimental Medicine|July 1, 1996
Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptorM Roth, M Nauck, S Yousefi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cellsT Quaschning, M Königer, A Krämer-Guth, et al.
Journal of Lipid Research|April 21, 1998
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemiaW März, M M Hoffmann, H Scharnagl, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 4, 2012
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trialM Nauck, E Horton, M Andjelkovic, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patientsT Quaschning, M Schömig, M Keller, et al.
International Journal of Andrology|January 12, 2010
Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of menR Haring, S E Baumeister, H Völzke, et al.
Deutsche Medizinische Wochenschrift (1946)|February 6, 2014
[TSH-reference range of adults: results from the population-based study KORA F4]K Burkhardt, T Ittermann, M Heier, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]M Nauck, S del Prato, J J Meier, et al.
Klinische Wochenschrift|January 4, 1990
Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresisU Kaboth, K W Rumpf, T Lipp, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|January 4, 1994
A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8R Ziesche, M Roth, E Papakonstantinou, et al.
The Journal of Experimental Medicine|July 1, 1996
Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptorM Roth, M Nauck, S Yousefi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cellsT Quaschning, M Königer, A Krämer-Guth, et al.
Journal of Lipid Research|April 21, 1998
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemiaW März, M M Hoffmann, H Scharnagl, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 4, 2012
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trialM Nauck, E Horton, M Andjelkovic, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patientsT Quaschning, M Schömig, M Keller, et al.
International Journal of Andrology|January 12, 2010
Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of menR Haring, S E Baumeister, H Völzke, et al.
Deutsche Medizinische Wochenschrift (1946)|February 6, 2014
[TSH-reference range of adults: results from the population-based study KORA F4]K Burkhardt, T Ittermann, M Heier, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]M Nauck, S del Prato, J J Meier, et al.
Klinische Wochenschrift|January 4, 1990
Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresisU Kaboth, K W Rumpf, T Lipp, et al.
Pageof 17